Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 23, Number 5—May 2017

Research

Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection

Matthew H. CollinsComments to Author , Eileen McGowan, Ramesh Jadi, Ellen Young, Cesar A. Lopez, Ralph S. Baric, Helen M. Lazear, and Aravinda M. de SilvaComments to Author 
Author affiliations: University of North Carolina, Chapel Hill, North Carolina, USA

Main Article

Table 3

50% Inhibitory concentrations for serum in depletion experiments of DENV and Zika virus*

Serum sample ID
DENV-2
DENV-4
Zika virus
DT000
Control 744 612 29
Depleted
<20
<20
<20
DT001
Control 1,376 60 <20
Depleted
331
24
<20
DT168
Control 83 48 1,978
Depleted
<20
<20
2,351
DT172
Control 22 32 2,341
Depleted
<20
<20
2,046
DT165
Control 198 162 3,067
Depleted
31
78
2,060
DT166
Control 1,556 1,138 1,090
Depleted <20 126 873

*DENV, dengue virus; ID, identification. Specific antibodies were depleted using beads coated with DENV1 and DENV2 antigens. Beads coated with BSA were used as a control.

Main Article

TOP